A Mixed Bag | GenomeWeb

A Mixed Bag

Using genetic testing before prescribing blood thinners has shown mixed results, NPR's Shots blog says. The blood thinner Plavix does carry a warning saying that people whose genes show they are a slow metabolizer of the drug may not get a benefit from taking it, but doctors aren't sure if they should test patients and, if they do, they don't know what to do if a patient is a slow metabolizer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.